What's the over/under on when this place goes out of business? The FDA letter is a killer. I hear some reps and former reps may file a class action suit for being told to mislead customers about surgical indications and off label usage.[/QUOTEI
If the FDA letter is a "killer", then we're in a lot of trouble in this country, and its unrelated to ACell. Every pharma and device company out there has warning letters. And most of the time, they're for issues far more serious than the stuff in the ACell's letter.
As for your over/under, I'm willing to bet the opposite. I see the company continuing on the same path its been on for the last 2 years, and some bigger company gobbling it up because its technology is best in class. A big company will have the manpower and money to do scores of trials to prove what doctors already know (and what materials managers people don't care about, because they don't care about healing patients, just reimbursement).
As for 'class action'? hah! Make sure you remind the reps to check their training materials. They were trained on the indications, but if they didn't listen that's their own issue. Beyond training, if they weren't intelligent enough to know their own products proper indications, then they shouldn't have been hired in the first place. How are you supposed to sell something if you don't even know what its used for?
